ConductScience.org, home

Paper33929324

CD8+ T cell self-tolerance permits responsiveness but limits tissue damage.

Truckenbrod EN and 10 others. Elife, 2021. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. CD8+ T cell self-tolerance permits responsiveness but limits tissue damage. Papers, record 33929324. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33929324

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CD8+ T cell self-tolerance permits responsiveness but limits tissue damage.
PubMed
Journal
Elife
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2021-11-22
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Truckenbrod ENEmily Nhttps://orcid.org/0000-0002-3819-6307
2Burrack KSKristina S
3Knutson TPTodd Phttps://orcid.org/0000-0001-8431-9964
4Borges da Silva HHenrique
5Block KEKatharine E
6O'Flanagan SDStephen D
7Stagliano KRKatie R
8Hurwitz AAArthur A
9Fulton RBRoss B
10Renkema KRKristin R
11Jameson SCStephen Chttps://orcid.org/0000-0001-9137-1146

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD8-Positive T-LymphocytesMajor topic
Self ToleranceMajor topic
Animals
Cell Differentiation
Female
Interleukin-2 Receptor alpha Subunit
Intramolecular Oxidoreductases
Male
Mice
Mice, Inbred C57BL
Vitiligo

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 OD010993NIH HHSUnited StatesT32OD010993PubMed and NIHNIH RePORTER
T32 CA009138NCI NIH HHSUnited StatesT32CA009138PubMed and NIHNIH RePORTER
P01 AI035296NIAID NIH HHSUnited StatesP01AI035296PubMed and NIHNIH RePORTER
R01 AI140631NIAID NIH HHSUnited StatesR01AI140631PubMed and NIHNIH RePORTER

Download CSV of grants

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124907378IL-2: the first effective immunotherapy for human cancer.J Immunol2014https://conductscience.org/library/papers/24907378PubMed
29858516CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity.J Exp Med1998https://conductscience.org/library/papers/9858516PubMed
316879996T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity.Immunity2006https://conductscience.org/library/papers/16879996PubMed
419903852Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects.Cancer Res2009https://conductscience.org/library/papers/19903852PubMed
525992863Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes.Immunity2015https://conductscience.org/library/papers/25992863PubMed
629608179Integrating single-cell transcriptomic data across different conditions, technologies, and species.Nat Biotechnol2018https://conductscience.org/library/papers/29608179PubMed
71901764Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.Cell1991https://conductscience.org/library/papers/1901764PubMed
818424696Cutting edge: Enhanced IL-2 signaling can convert self-specific T cell response from tolerance to autoimmunity.J Immunol2008https://conductscience.org/library/papers/18424696PubMed
917382557Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation.Semin Immunol2007https://conductscience.org/library/papers/17382557PubMed
1028648661De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation.Cell2017https://conductscience.org/library/papers/28648661PubMed
1121220453High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses.J Exp Med2011https://conductscience.org/library/papers/21220453PubMed
1217086201Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling.Nature2006https://conductscience.org/library/papers/17086201PubMed
1311163198Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion.Immunity2000https://conductscience.org/library/papers/11163198PubMed
1416200080Central tolerance: learning self-control in the thymus.Nat Rev Immunol2005https://conductscience.org/library/papers/16200080PubMed
1522987800Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection.J Exp Med2012https://conductscience.org/library/papers/22987800PubMed
1629925986Thymic tolerance as a key brake on autoimmunity.Nat Immunol2018https://conductscience.org/library/papers/29925986PubMed
1715780985Peripheral tolerance of CD8 T lymphocytes.Immunity2005https://conductscience.org/library/papers/15780985PubMed
1819182777Complete but curtailed T-cell response to very low-affinity antigen.Nature2009https://conductscience.org/library/papers/19182777PubMed
1918759926Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.Immunol Rev2008https://conductscience.org/library/papers/18759926PubMed
2016778891Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.Nature2006https://conductscience.org/library/papers/16778891PubMed

See all 70 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42086715CD8+ T cells in atherosclerosis and coronary artery disease.Nat Rev Cardiol2026https://conductscience.org/library/papers/42086715PubMed
41491403Targeting autocrine retinoic acid signaling by ALDH1A2 inhibition enhances antitumor dendritic cell vaccine efficacy.Nat Immunol2026https://conductscience.org/library/papers/41491403PubMed
41482575The immunology of vitiligo.Nat Rev Immunol2026https://conductscience.org/library/papers/41482575PubMed
39801736T Cell Resistance: On the Mechanisms of T Cell Non-activation.Immune Netw2024https://conductscience.org/library/papers/39801736PubMed
38776918The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects.Immunity2024https://conductscience.org/library/papers/38776918PubMed
38571942Activated B-Cells enhance epitope spreading to support successful cancer immunotherapy.Front Immunol2024https://conductscience.org/library/papers/38571942PubMed
36100367Strong Basal/Tonic TCR Signals Are Associated with Negative Regulation of Naive CD4+ T Cells.Immunohorizons2022https://conductscience.org/library/papers/36100367PubMed
34653787Functional heterogeneity and adaptation of naive T cells in response to tonic TCR signals.Curr Opin Immunol2021https://conductscience.org/library/papers/34653787PubMed
33929324CD8+ T cell self-tolerance permits responsiveness but limits tissue damage.Elife2021https://conductscience.org/library/papers/33929324PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
TRBV20OR9-26962PubTator's text mininghttps://conductscience.org/library/genes/6962NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GEOGSE171221

Source GEO

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33929324

GET https://conductscience.org/api/papers/v1/33929324/references?page=2